Aldeyra Therapeutics, Inc. - stock earnings
ALDX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.14 / -0.11 | - | - / 2.0 million | - |
ALDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.2 million USD | ? USD |
| 2023Q2 | -9.0 million USD | ? USD |
| 2023Q1 | -14.9 million USD | ? USD |
| 2022Q4 | -12.1 million USD | ? USD |
| 2022Q3 | -14.3 million USD | ? USD |
| 2022Q2 | -17.8 million USD | ? USD |
| 2022Q1 | -17.1 million USD | ? USD |
| 2021Q4 | -15.8 million USD | ? USD |
| 2021Q3 | -15.8 million USD | ? USD |
| 2021Q2 | -14.9 million USD | ? USD |
| 2021Q1 | -11.3 million USD | ? USD |
| 2020Q4 | -11.3 million USD | ? USD |
| 2020Q3 | -8.9 million USD | ? USD |
| 2020Q2 | -7.5 million USD | ? USD |
| 2020Q1 | -9.9 million USD | ? USD |
| 2019Q4 | -13.2 million USD | ? USD |
| 2019Q3 | -18.7 million USD | ? USD |
| 2019Q2 | -13.3 million USD | ? USD |
| 2019Q1 | -15.6 million USD | ? USD |
| 2018Q4 | -10.6 million USD | ? USD |
| 2018Q3 | -10.8 million USD | ? USD |
| 2018Q2 | -9.1 million USD | ? USD |
| 2018Q1 | -8.4 million USD | 8.3 million USD |
| 2017Q4 | -7.0 million USD | 24.1 trillion USD |
| 2017Q3 | -5.0 million USD | ? USD |
| 2017Q2 | -5.3 million USD | ? USD |
| 2017Q1 | -5.1 million USD | 4.0 million USD |
| 2016Q4 | -4.7 million USD | 16.1 million USD |
| 2016Q3 | -4.8 million USD | ? USD |
| 2016Q2 | -4.3 million USD | ? USD |
| 2016Q1 | -5.0 million USD | ? USD |
| 2015Q4 | -4.4 million USD | -264984 USD |
| 2015Q3 | -3.4 million USD | ? USD |
| 2015Q2 | -2.2 million USD | ? USD |
| 2015Q1 | -2.1 million USD | ? USD |
| 2014Q4 | -2.4 million USD | ? USD |
| 2014Q3 | -2.0 million USD | ? USD |
| 2014Q2 | -1.1 million USD | ? USD |
| 2014Q1 | 401773 USD | ? USD |
| 2013Q4 | 9.3 million USD | ? USD |
| 2013Q3 | 9.3 million USD | ? USD |
| 2013Q2 | -1.6 million USD | ? USD |
| 2013Q1 | -4.0 million USD | ? USD |
| 2012Q4 | -21.7 million USD | ? USD |
ALDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -45.7 million USD | ? USD |
| 2022 | -61.4 million USD | ? USD |
| 2021 | -59.3 million USD | ? USD |
| 2020 | -37.6 million USD | ? USD |
| 2019 | -60.8 million USD | ? USD |
| 2018 | -38.9 million USD | ? USD |
| 2017 | -22.3 million USD | ? USD |
| 2016 | -18.7 million USD | ? USD |
| 2015 | -12.1 million USD | ? USD |
| 2014 | -5.2 million USD | ? USD |
| 2013 | 13.1 million USD | ? USD |
| 2012 | -23.1 million USD | ? USD |
| 2011 | -2.4 million USD | ? USD |
ALDX
Price: $4.21
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -4
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 79624
Ebitda: -4.9 millionMarket Capitalization: 250.3 million